Psych MEQs / SAQs · Specialty psychiatry — sleep medicine interface
Adolescent delayed sleep-wake phase with school failure (MEQ)
FRANZCP-style MEQ on DSWPD: free-day recovery pattern, light/melatonin timing, school failure framing, ADHD interface. FRANZCP-primary, globally tagged.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Formulation. Delayed sleep-wake phase disorder (DSWPD): delayed sleep onset/offset, daytime impairment when forced to early schedule, and relatively restorative sleep on a free delayed schedule — the “holiday sleep test.” Contributing factors: developmental evening chronotype, evening phone light, possible ADHD traits, family conflict/stigma (“laziness”). Differentials: chronic insomnia disorder (less likely if free-day sleep is good), school refusal without circadian driver (can coexist), OSA (low pretest here), substance use, emerging mood disorder with reduced need (no elevated mood in stem), non-24 (no progressive free-running described).[1][5][6]
(ii) Assessment. Structured chronotype and schedule history (workday vs free-day mid-sleep); 1–2 week sleep diary; actigraphy if available; light/screen inventory; substances; mood/psychosis/suicide risk; ADHD screen after sleep opportunity considered; school attendance pattern and family dynamics; driving if relevant. PSG not first-line pure CRSWD. Consider DLMO if specialist pathway available for precision timing.[5][7]
(iii) Mechanisms. Two-process model: Process S (homeostatic) and Process C (SCN circadian). DSWPD is primarily Process C delay. PRC: morning light advances; evening light delays; melatonin roughly opposite light. Evening screens reinforce delay. Melatonin must be timed as a chronobiotic relative to desired bedtime/DLMO, not a random nightcap.[3][7]
(iv) Treatment plan. Psychoeducation to parents and young person — medical timing disorder, not moral failure. Fixed morning rise time with morning bright light; protect dark evenings (dim light, reduce phone in bed). Strategically timed melatonin: Sletten-order 0.5 mg orally about 1 hour before desired bedtime with behavioural scheduling (attempt sleep at desired bedtime most nights); Mundey-order teaching that advance magnitude depends on timing relative to DLMO; meta-analysis supports melatonin for DSWPD phase/latency outcomes.[2][3][4] Avoid long-term benzodiazepine/Z-drug as primary strategy.[6] Follow with diary/actigraphy; step to sleep medicine if refractory.
(v) System and pitfalls. School liaison: temporary adjusted start, graded return, medical letter explaining DSWPD. Reassess ADHD when sleep opportunity improves — do not attribute all inattention to character. Pitfalls: shaming, melatonin at wrong phase, escalating sedatives, missing mood disorder, chronotherapy without adherence support.[1][6]
References
- [1]Auger RR, Burgess HJ, Emens JS, et al. Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline J Clin Sleep Med, 2015.PMID 26414986
- [2]Sletten TL, Magee M, Murray JM, et al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial PLoS Med, 2018.PMID 29912983
- [3]Mundey K, Benloucif S, Harsanyi K, et al. Phase-dependent treatment of delayed sleep phase syndrome with melatonin Sleep, 2005.PMID 16295212
- [4]van Geijlswijk IM, Korzilius HP, Smits MG The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis Sleep, 2010.PMID 21120122
- [5]Sack RL, Auckley D, Auger RR, et al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review Sleep, 2007.PMID 18041481
- [6]Wilson S, Anderson K, Baldwin D, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update J Psychopharmacol, 2019.PMID 31271339
- [7]Sack RL, Auckley D, Auger RR, et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review Sleep, 2007.PMID 18041480